Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Zachou

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
European Journal of Clinical Investigation|February 18, 2003
Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndromeK Zachou, C Liaskos, D K Christodoulou, et al.
Gut|March 9, 2005
Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosisE I Rigopoulou, E T Davies, A Pares, et al.
Vaccine|June 28, 2008
Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073P Fytili, G N Dalekos, V Schlaphoff, et al.
Journal of Viral Hepatitis|May 11, 2012
Renal function during treatment with adefovir plus peginterferon alfa-2a vs either drug alone in hepatitis B/D co-infectionI Mederacke, C Yurdaydin, A Großhennig, et al.
Journal of Viral Hepatitis|April 14, 2006
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experienceH L Tillmann, J Hadem, L Leifeld, et al.
Alimentary Pharmacology & Therapeutics|July 23, 2016
HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of responseG A Niro, A Smedile, R Fontana, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
European Journal of Clinical Investigation|February 18, 2003
Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndromeK Zachou, C Liaskos, D K Christodoulou, et al.
Gut|March 9, 2005
Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosisE I Rigopoulou, E T Davies, A Pares, et al.
Vaccine|June 28, 2008
Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073P Fytili, G N Dalekos, V Schlaphoff, et al.
Journal of Viral Hepatitis|May 11, 2012
Renal function during treatment with adefovir plus peginterferon alfa-2a vs either drug alone in hepatitis B/D co-infectionI Mederacke, C Yurdaydin, A Großhennig, et al.
Journal of Viral Hepatitis|April 14, 2006
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experienceH L Tillmann, J Hadem, L Leifeld, et al.
Alimentary Pharmacology & Therapeutics|July 23, 2016
HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of responseG A Niro, A Smedile, R Fontana, et al.
Pageof 2